Cue Biopharma, Inc.
General ticker "CUE" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $45.9M (TTM average)
Cue Biopharma, Inc. does not follow the US Stock Market performance with the rate: -1.0%.
Estimated limits based on current volatility of 4.6%: low 0.56$, high 0.62$
Factors to consider:
- Total employees count: 53 (+1.9%) as of 2023
- Top business risk factors: Lack of profitability, High R&D costs, Regulatory and compliance, Third-party risks, Need for additional capital
- Current price 27.7% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.76$, 2.15$]
- 2025-12-31 to 2026-12-31 estimated range: [0.86$, 2.35$]
Financial Metrics affecting the CUE estimates:
- Positive: with PPE of -1.4 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -61.88 <= 0.33
- Positive: 41.86 < Shareholder equity ratio, % of 54.36 <= 63.39
- Positive: Investing cash flow per share per price, % of 0.05 > -0.66
- Negative: negative Industry operating cash flow (median)
Short-term CUE quotes
Long-term CUE plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $1.25MM | $5.49MM | $9.29MM |
| Operating Expenses | $54.47MM | $57.64MM | $50.79MM |
| Operating Income | $-53.23MM | $-52.15MM | $-41.50MM |
| Non-Operating Income | $0.21MM | $1.42MM | $0.83MM |
| Interest Expense | $0.71MM | $1.25MM | $0.80MM |
| R&D Expense | $38.58MM | $40.80MM | $36.30MM |
| Income(Loss) | $-53.01MM | $-50.73MM | $-40.67MM |
| Profit(Loss)* | $-53.01MM | $-50.73MM | $-40.67MM |
| Stockholders Equity | $65.68MM | $37.09MM | $17.50MM |
| Assets | $91.28MM | $61.53MM | $32.19MM |
| Operating Cash Flow | $-41.81MM | $-39.96MM | $-36.33MM |
| Capital expenditure | $0.17MM | $0.00MM | $0.07MM |
| Investing Cash Flow | $-24.61MM | $25.00MM | $0.03MM |
| Financing Cash Flow | $53.66MM | $11.86MM | $10.24MM |
| Earnings Per Share** | $-1.49 | $-1.11 | $-0.72 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.